Fourthly, there is no mention of race-based guidance for the use of ACE inhibitors in British NICE guidance such as in heart failure [19] or post-myocardial infarction [20] possibly as the cardio-protective rather than anti-hypertensive effect of prescribed medications is desired. Here, ACE is linked to heart failure.